1,488
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1)

, , , , , & ORCID Icon show all
Pages 6713-6723 | Received 28 Jul 2021, Accepted 18 Aug 2021, Published online: 14 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Na He, Linbiao Xiang, Lei Chen, Haobin Tong, Keshen Wang, Jie Zhao, Feixue Song, Hanteng Yang, Xinyuan Wei & Zuoyi Jiao. (2022) The role of long non-coding RNA FGD5-AS1 in cancer. Bioengineered 13:4, pages 11026-11041.
Read now
Huixiong Wang, Xin Zhang, Xiaoting Chen, Shengbin Zhang, Zhelin Yun, Qiang Gao, Haitao Sheng & Junjie Wang. (2022) Long non-coding RNA placenta‑specific protein 2 regulates the chemosensitivity of cancer cells to cisplatin in hepatocellular carcinoma (HCC) by sponging microRNA-96 to upregulate X-linked inhibitor of apoptosis protein. Bioengineered 13:4, pages 10765-10773.
Read now

Articles from other publishers (9)

Saade Abdalkareem Jasim, Ali A. Majeed, Herlina Uinarni, Mohammed Alshuhri, Abdullah Ali Alzahrani, Abeer A. Ibrahim, Ahmed Alawadi, Noor K. Abed Al-Abadi, Yasser Fakri Mustafa & Batool Ali Ahmed. (2024) Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms. Pathology - Research and Practice 254, pages 155119.
Crossref
Imene Arab, Jeongkwang Park, Jae-Joon Shin, Hyeung-Seob Shin, Kyoungho Suk & Won-Ha Lee. (2023) Macrophage lncRNAs in cancer development: Long-awaited therapeutic targets. Biochemical Pharmacology 218, pages 115890.
Crossref
Yu Wang, Ran Zuo, Gengwei Huo, Zhiqiang Han, Yuchao He, Yi Luo, Liwei Chen, Guangtao Li, Jinfang Cui, Fuyi Zhu, Ping Yue, Dongqi Yuan, Yi Sun, Zhaoyue Li, Peng Chen & Hua Guo. (2023) TWF1 induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the cAMP signaling pathway . The FASEB Journal 37:7.
Crossref
Yuan Fang, XiaoLi Zhang, HanFei Huang & Zhong Zeng. (2023) The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Journal of Translational Medicine 21:1.
Crossref
Nicola Mosca, Aniello Russo & Nicoletta Potenza. (2023) Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:10, pages 8886.
Crossref
Mehrdad Hashemi, Sepideh Mirzaei, Mohammad Arad Zandieh, Sahar Rezaei, Amirabbas kakavand, Amir Dehghanpour, Negin Esmaeili, Azin Ghahremanzade, Hamidreza Saebfar, Hajar Heidari, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari & Kwang Seok Ahn. (2023) Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Progress in Biophysics and Molecular Biology 177, pages 207-228.
Crossref
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida & Stavroula Baritaki. (2022) Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 65, pages 100866.
Crossref
Xuehao Zhou, Xiang Ao, Zhaojun Jia, Yiwen Li, Shouxiang Kuang, Chengcheng Du, Jinyu Zhang, Jianxun Wang & Ying Liu. (2022) Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. Frontiers in Oncology 12.
Crossref
Ming Liu & Jingwei Peng. (2022) FTX Regulated miR-153-3p/FOXR2 to Promote Cisplatin Resistance in Ovarian Cancer. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref